Home > Boards > US Listed > Medical - Drugs >

Novartis (NVS)

NVS RSS Feed
Add NVS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/8/2019 10:18:26 AM - Followers: 19 - Board type: Free - Posts Today: 0
NVS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVS News: Novartis (NVS) Alert: Johnson Fistel Launches Investigation into Novartis AG; Investors Encouraged to Contact Firm 08/07/2019 07:42:00 PM
NVS News: Long-term Survival Benefit Shown for Metastatic Melanoma Patients Treated with Novartis Tafinlar® + Mekinist® 06/04/2019 01:03:00 PM
NVS News: Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clin... 06/03/2019 01:19:00 AM
NVS News: AveXis receives FDA approval for Zolgensma®, the first and only gene therapy for pediatric patients with spinal muscular atr... 05/24/2019 01:09:00 PM
NVS News: New Gene Therapies Hold Out Promise for Patients 05/07/2019 08:45:00 AM
PostSubject
#384   FDA approves NVS’ Beovu—(a/k/a brolucizumab/RTH258) for wet AMD—3mo DewDiligence 10/08/19 10:18:25 AM
#383   Here's the cause of today's sell-off: DewDiligence 08/06/19 03:10:04 PM
#382   Any clue what too the air out this Ecomike 08/06/19 03:04:54 PM
#381   I would love to hear more about that Ecomike 07/12/19 11:54:34 AM
#380   Novartis been researching PS Phosphatidylserine targeting ? biopharm 05/28/19 07:41:28 AM
#379   Green after hours trading PennyStock Alert 05/25/19 11:46:59 AM
#378   Nice news ! PennyStock Alert 05/24/19 02:02:44 PM
#377   News: $NVS AveXis receives FDA approval for Zolgensma®, whytestocks 05/24/19 01:20:40 PM
#376   NVS Investor Day slides: DewDiligence 05/23/19 11:43:54 AM
#375   NVS PR accompanying today’s Investor Day webcast: DewDiligence 05/23/19 11:30:11 AM
#374   NVS’ QVM149* scores in phase-2 asthma trial, showing DewDiligence 05/22/19 12:30:29 PM
#373   NVS acquires Xiidra from Takeda for $3.4B up-front DewDiligence 05/08/19 07:23:44 PM
#372   AMGN and NVS are at war over Aimovig, DewDiligence 05/02/19 07:26:40 PM
#371   NVS shares declined on 4/9/19 by the implied DewDiligence 04/26/19 05:34:15 PM
#370   Higher PE sounds sweet :-) Ecomike 04/26/19 05:00:39 PM
#369   The ALC spin-off did not benefit NVS itself DewDiligence 04/26/19 04:41:54 PM
#368   DD, do you know what if anything NVS Ecomike 04/26/19 04:25:41 PM
#367   NVS completes separation of Alcon, which is now DewDiligence 04/09/19 06:41:47 PM
#366   NVS sues AMGN re Aimovig collaboration termination: DewDiligence 04/04/19 02:50:48 PM
#365   FDA approves NVS’ Mayzent* for MS—including SPMS: DewDiligence 03/26/19 07:49:22 PM
#364   If NVS Does BO AMRN, Invest83838 02/22/19 11:32:46 AM
#363   WSJ opines on the “new” Novartis: DewDiligence 11/19/18 11:06:25 AM
#362   NVS R&D Day slides (170 pages): DewDiligence 11/05/18 08:53:13 AM
#361   PFE-NVS clinical-trial collaboration in NASH: #msg-144519047. DewDiligence 10/29/18 10:14:56 AM
#360   NVS 3Q18 results: DewDiligence 10/18/18 04:05:46 PM
#359   NVS receives CRL for Ilaris in CVD: #msg-144301592. DewDiligence 10/18/18 10:34:34 AM
#358   NVS acquires ECYT for $2.1B: DewDiligence 10/18/18 10:33:30 AM
#357   AMGN, NVS launch Humira biosimilars in Europe, pursuant DewDiligence 10/16/18 11:24:18 AM
#356   ABBV settles global Humira-patent litigation with NVS: #msg-144157243. DewDiligence 10/11/18 05:24:02 PM
#355   PDUFA date for NVS’ BAF312 in SPMS—>Mar 2019 DewDiligence 10/08/18 10:01:36 AM
#354   Doctors and insurance companies will soon get wise DewDiligence 10/04/18 09:36:05 AM
#353   Entresto will flop debunker1 10/04/18 06:10:41 AM
#352   NVS sells US small-molecule-generics business to India’s Aurobindo DewDiligence 09/06/18 11:18:26 AM
#351   NVS 2Q18 PR: DewDiligence 07/18/18 11:25:34 AM
#350   NVS reports soft 2Q18—but re-iterates full-year guidance: DewDiligence 07/18/18 05:23:02 AM
#348   NVS seeks to divest Alcon—will take enormous loss DewDiligence 06/29/18 09:39:31 AM
#347   Entresto is nothing more than an attempt by debunker1 06/09/18 03:23:21 PM
#346   NVS slides from “Meet the Management” Investor Day: DewDiligence 05/16/18 12:51:12 PM
#345   Data support 12-week dosing of RTH258 for some DewDiligence 04/30/18 04:35:21 PM
#344   FDA approves Tafinlar/Mekinist for adjuvant BRAF-V600+ melanoma: DewDiligence 04/30/18 04:22:15 PM
#343   NVS acquires AVXS for $8.7B in cash: DewDiligence 04/09/18 02:55:20 PM
#342   NVS PR on consumer-JV sale to GSK: DewDiligence 03/27/18 09:44:25 AM
#341   NVS seeking bids for US small-molecule-generics business: DewDiligence 02/16/18 04:27:12 PM
#340   :-) :-) :-) Ecomike 01/24/18 02:33:11 PM
#339   NVS 4Q17 results… DewDiligence 01/24/18 09:10:05 AM
#338   NVS hires oncology chief (from PFE): DewDiligence 01/11/18 10:40:04 AM
#337   Novartis been researching PS Phosphatidylserine targeting ? biopharm 01/06/18 08:11:48 AM
#336   The market is overvalued and overbought, and 2018's sokol 12/29/17 08:53:44 PM
#335   NVS’ Investor Day PR and slides: DewDiligence 11/13/17 02:13:56 PM
#334   https://seekingalpha.com/article/4124174-novartis-looks-challenge-regenerons-tur Inoviorulez 11/13/17 08:13:36 AM
PostSubject